Global Amyloidosis Therapeutics Market Research Report 2024(Status and Outlook)
Report Overview:
The Global Amyloidosis Therapeutics Market Size was estimated at USD 4855.42 million in 2023 and is projected to reach USD 6619.07 million by 2029, exhibiting a CAGR of 5.30% during the forecast period.
This report provides a deep insight into the global Amyloidosis Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Amyloidosis Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Amyloidosis Therapeutics market in any manner.
Global Amyloidosis Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer Inc.
ProteoTech, Inc.
Alnylam Pharmaceuticals, Inc.
Arcturus Therapeutics, Inc
Bellus Health Inc.
Bsim2
Celgene Corporation
Millennium Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc.
GlaxoSmithKline Plc
Isis Pharmaceuticals, Inc.
Prothena Corporation Plc
SOM Innovation Biotech SL
Market Segmentation (by Type)
AG-10
ALN-ANG
ALN-TTRsc02
CAEL-101
Canakinumab
Others
Market Segmentation (by Application)
AL Amyloidosis
AA Amyloidoses
ATTR Amyloidoses
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Amyloidosis Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
The Global Amyloidosis Therapeutics Market Size was estimated at USD 4855.42 million in 2023 and is projected to reach USD 6619.07 million by 2029, exhibiting a CAGR of 5.30% during the forecast period.
This report provides a deep insight into the global Amyloidosis Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Amyloidosis Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Amyloidosis Therapeutics market in any manner.
Global Amyloidosis Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer Inc.
ProteoTech, Inc.
Alnylam Pharmaceuticals, Inc.
Arcturus Therapeutics, Inc
Bellus Health Inc.
Bsim2
Celgene Corporation
Millennium Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc.
GlaxoSmithKline Plc
Isis Pharmaceuticals, Inc.
Prothena Corporation Plc
SOM Innovation Biotech SL
Market Segmentation (by Type)
AG-10
ALN-ANG
ALN-TTRsc02
CAEL-101
Canakinumab
Others
Market Segmentation (by Application)
AL Amyloidosis
AA Amyloidoses
ATTR Amyloidoses
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Amyloidosis Therapeutics Market
- Overview of the regional outlook of the Amyloidosis Therapeutics Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Amyloidosis Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Amyloidosis Therapeutics
1.2 Key Market Segments
1.2.1 Amyloidosis Therapeutics Segment by Type
1.2.2 Amyloidosis Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 AMYLOIDOSIS THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Amyloidosis Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Amyloidosis Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 AMYLOIDOSIS THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Amyloidosis Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Amyloidosis Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Amyloidosis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Amyloidosis Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Amyloidosis Therapeutics Sales Sites, Area Served, Product Type
3.6 Amyloidosis Therapeutics Market Competitive Situation and Trends
3.6.1 Amyloidosis Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Amyloidosis Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 AMYLOIDOSIS THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Amyloidosis Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF AMYLOIDOSIS THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 AMYLOIDOSIS THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Amyloidosis Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Amyloidosis Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Amyloidosis Therapeutics Price by Type (2019-2024)
7 AMYLOIDOSIS THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Amyloidosis Therapeutics Market Sales by Application (2019-2024)
7.3 Global Amyloidosis Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Amyloidosis Therapeutics Sales Growth Rate by Application (2019-2024)
8 AMYLOIDOSIS THERAPEUTICS MARKET SEGMENTATION BY REGION
8.1 Global Amyloidosis Therapeutics Sales by Region
8.1.1 Global Amyloidosis Therapeutics Sales by Region
8.1.2 Global Amyloidosis Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Amyloidosis Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Amyloidosis Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Amyloidosis Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Amyloidosis Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Amyloidosis Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Pfizer Inc.
9.1.1 Pfizer Inc. Amyloidosis Therapeutics Basic Information
9.1.2 Pfizer Inc. Amyloidosis Therapeutics Product Overview
9.1.3 Pfizer Inc. Amyloidosis Therapeutics Product Market Performance
9.1.4 Pfizer Inc. Business Overview
9.1.5 Pfizer Inc. Amyloidosis Therapeutics SWOT Analysis
9.1.6 Pfizer Inc. Recent Developments
9.2 ProteoTech, Inc.
9.2.1 ProteoTech, Inc. Amyloidosis Therapeutics Basic Information
9.2.2 ProteoTech, Inc. Amyloidosis Therapeutics Product Overview
9.2.3 ProteoTech, Inc. Amyloidosis Therapeutics Product Market Performance
9.2.4 ProteoTech, Inc. Business Overview
9.2.5 ProteoTech, Inc. Amyloidosis Therapeutics SWOT Analysis
9.2.6 ProteoTech, Inc. Recent Developments
9.3 Alnylam Pharmaceuticals, Inc.
9.3.1 Alnylam Pharmaceuticals, Inc. Amyloidosis Therapeutics Basic Information
9.3.2 Alnylam Pharmaceuticals, Inc. Amyloidosis Therapeutics Product Overview
9.3.3 Alnylam Pharmaceuticals, Inc. Amyloidosis Therapeutics Product Market Performance
9.3.4 Alnylam Pharmaceuticals, Inc. Amyloidosis Therapeutics SWOT Analysis
9.3.5 Alnylam Pharmaceuticals, Inc. Business Overview
9.3.6 Alnylam Pharmaceuticals, Inc. Recent Developments
9.4 Arcturus Therapeutics, Inc
9.4.1 Arcturus Therapeutics, Inc Amyloidosis Therapeutics Basic Information
9.4.2 Arcturus Therapeutics, Inc Amyloidosis Therapeutics Product Overview
9.4.3 Arcturus Therapeutics, Inc Amyloidosis Therapeutics Product Market Performance
9.4.4 Arcturus Therapeutics, Inc Business Overview
9.4.5 Arcturus Therapeutics, Inc Recent Developments
9.5 Bellus Health Inc.
9.5.1 Bellus Health Inc. Amyloidosis Therapeutics Basic Information
9.5.2 Bellus Health Inc. Amyloidosis Therapeutics Product Overview
9.5.3 Bellus Health Inc. Amyloidosis Therapeutics Product Market Performance
9.5.4 Bellus Health Inc. Business Overview
9.5.5 Bellus Health Inc. Recent Developments
9.6 Bsim2
9.6.1 Bsim2 Amyloidosis Therapeutics Basic Information
9.6.2 Bsim2 Amyloidosis Therapeutics Product Overview
9.6.3 Bsim2 Amyloidosis Therapeutics Product Market Performance
9.6.4 Bsim2 Business Overview
9.6.5 Bsim2 Recent Developments
9.7 Celgene Corporation
9.7.1 Celgene Corporation Amyloidosis Therapeutics Basic Information
9.7.2 Celgene Corporation Amyloidosis Therapeutics Product Overview
9.7.3 Celgene Corporation Amyloidosis Therapeutics Product Market Performance
9.7.4 Celgene Corporation Business Overview
9.7.5 Celgene Corporation Recent Developments
9.8 Millennium Pharmaceuticals, Inc.
9.8.1 Millennium Pharmaceuticals, Inc. Amyloidosis Therapeutics Basic Information
9.8.2 Millennium Pharmaceuticals, Inc. Amyloidosis Therapeutics Product Overview
9.8.3 Millennium Pharmaceuticals, Inc. Amyloidosis Therapeutics Product Market Performance
9.8.4 Millennium Pharmaceuticals, Inc. Business Overview
9.8.5 Millennium Pharmaceuticals, Inc. Recent Developments
9.9 Onyx Pharmaceuticals, Inc.
9.9.1 Onyx Pharmaceuticals, Inc. Amyloidosis Therapeutics Basic Information
9.9.2 Onyx Pharmaceuticals, Inc. Amyloidosis Therapeutics Product Overview
9.9.3 Onyx Pharmaceuticals, Inc. Amyloidosis Therapeutics Product Market Performance
9.9.4 Onyx Pharmaceuticals, Inc. Business Overview
9.9.5 Onyx Pharmaceuticals, Inc. Recent Developments
9.10 GlaxoSmithKline Plc
9.10.1 GlaxoSmithKline Plc Amyloidosis Therapeutics Basic Information
9.10.2 GlaxoSmithKline Plc Amyloidosis Therapeutics Product Overview
9.10.3 GlaxoSmithKline Plc Amyloidosis Therapeutics Product Market Performance
9.10.4 GlaxoSmithKline Plc Business Overview
9.10.5 GlaxoSmithKline Plc Recent Developments
9.11 Isis Pharmaceuticals, Inc.
9.11.1 Isis Pharmaceuticals, Inc. Amyloidosis Therapeutics Basic Information
9.11.2 Isis Pharmaceuticals, Inc. Amyloidosis Therapeutics Product Overview
9.11.3 Isis Pharmaceuticals, Inc. Amyloidosis Therapeutics Product Market Performance
9.11.4 Isis Pharmaceuticals, Inc. Business Overview
9.11.5 Isis Pharmaceuticals, Inc. Recent Developments
9.12 Prothena Corporation Plc
9.12.1 Prothena Corporation Plc Amyloidosis Therapeutics Basic Information
9.12.2 Prothena Corporation Plc Amyloidosis Therapeutics Product Overview
9.12.3 Prothena Corporation Plc Amyloidosis Therapeutics Product Market Performance
9.12.4 Prothena Corporation Plc Business Overview
9.12.5 Prothena Corporation Plc Recent Developments
9.13 SOM Innovation Biotech SL
9.13.1 SOM Innovation Biotech SL Amyloidosis Therapeutics Basic Information
9.13.2 SOM Innovation Biotech SL Amyloidosis Therapeutics Product Overview
9.13.3 SOM Innovation Biotech SL Amyloidosis Therapeutics Product Market Performance
9.13.4 SOM Innovation Biotech SL Business Overview
9.13.5 SOM Innovation Biotech SL Recent Developments
10 AMYLOIDOSIS THERAPEUTICS MARKET FORECAST BY REGION
10.1 Global Amyloidosis Therapeutics Market Size Forecast
10.2 Global Amyloidosis Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Amyloidosis Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Amyloidosis Therapeutics Market Size Forecast by Region
10.2.4 South America Amyloidosis Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Amyloidosis Therapeutics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Amyloidosis Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Amyloidosis Therapeutics by Type (2025-2030)
11.1.2 Global Amyloidosis Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Amyloidosis Therapeutics by Type (2025-2030)
11.2 Global Amyloidosis Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Amyloidosis Therapeutics Sales (Kilotons) Forecast by Application
11.2.2 Global Amyloidosis Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Amyloidosis Therapeutics
1.2 Key Market Segments
1.2.1 Amyloidosis Therapeutics Segment by Type
1.2.2 Amyloidosis Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 AMYLOIDOSIS THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Amyloidosis Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Amyloidosis Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 AMYLOIDOSIS THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Amyloidosis Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Amyloidosis Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Amyloidosis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Amyloidosis Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Amyloidosis Therapeutics Sales Sites, Area Served, Product Type
3.6 Amyloidosis Therapeutics Market Competitive Situation and Trends
3.6.1 Amyloidosis Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Amyloidosis Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 AMYLOIDOSIS THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Amyloidosis Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF AMYLOIDOSIS THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 AMYLOIDOSIS THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Amyloidosis Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Amyloidosis Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Amyloidosis Therapeutics Price by Type (2019-2024)
7 AMYLOIDOSIS THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Amyloidosis Therapeutics Market Sales by Application (2019-2024)
7.3 Global Amyloidosis Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Amyloidosis Therapeutics Sales Growth Rate by Application (2019-2024)
8 AMYLOIDOSIS THERAPEUTICS MARKET SEGMENTATION BY REGION
8.1 Global Amyloidosis Therapeutics Sales by Region
8.1.1 Global Amyloidosis Therapeutics Sales by Region
8.1.2 Global Amyloidosis Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Amyloidosis Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Amyloidosis Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Amyloidosis Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Amyloidosis Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Amyloidosis Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Pfizer Inc.
9.1.1 Pfizer Inc. Amyloidosis Therapeutics Basic Information
9.1.2 Pfizer Inc. Amyloidosis Therapeutics Product Overview
9.1.3 Pfizer Inc. Amyloidosis Therapeutics Product Market Performance
9.1.4 Pfizer Inc. Business Overview
9.1.5 Pfizer Inc. Amyloidosis Therapeutics SWOT Analysis
9.1.6 Pfizer Inc. Recent Developments
9.2 ProteoTech, Inc.
9.2.1 ProteoTech, Inc. Amyloidosis Therapeutics Basic Information
9.2.2 ProteoTech, Inc. Amyloidosis Therapeutics Product Overview
9.2.3 ProteoTech, Inc. Amyloidosis Therapeutics Product Market Performance
9.2.4 ProteoTech, Inc. Business Overview
9.2.5 ProteoTech, Inc. Amyloidosis Therapeutics SWOT Analysis
9.2.6 ProteoTech, Inc. Recent Developments
9.3 Alnylam Pharmaceuticals, Inc.
9.3.1 Alnylam Pharmaceuticals, Inc. Amyloidosis Therapeutics Basic Information
9.3.2 Alnylam Pharmaceuticals, Inc. Amyloidosis Therapeutics Product Overview
9.3.3 Alnylam Pharmaceuticals, Inc. Amyloidosis Therapeutics Product Market Performance
9.3.4 Alnylam Pharmaceuticals, Inc. Amyloidosis Therapeutics SWOT Analysis
9.3.5 Alnylam Pharmaceuticals, Inc. Business Overview
9.3.6 Alnylam Pharmaceuticals, Inc. Recent Developments
9.4 Arcturus Therapeutics, Inc
9.4.1 Arcturus Therapeutics, Inc Amyloidosis Therapeutics Basic Information
9.4.2 Arcturus Therapeutics, Inc Amyloidosis Therapeutics Product Overview
9.4.3 Arcturus Therapeutics, Inc Amyloidosis Therapeutics Product Market Performance
9.4.4 Arcturus Therapeutics, Inc Business Overview
9.4.5 Arcturus Therapeutics, Inc Recent Developments
9.5 Bellus Health Inc.
9.5.1 Bellus Health Inc. Amyloidosis Therapeutics Basic Information
9.5.2 Bellus Health Inc. Amyloidosis Therapeutics Product Overview
9.5.3 Bellus Health Inc. Amyloidosis Therapeutics Product Market Performance
9.5.4 Bellus Health Inc. Business Overview
9.5.5 Bellus Health Inc. Recent Developments
9.6 Bsim2
9.6.1 Bsim2 Amyloidosis Therapeutics Basic Information
9.6.2 Bsim2 Amyloidosis Therapeutics Product Overview
9.6.3 Bsim2 Amyloidosis Therapeutics Product Market Performance
9.6.4 Bsim2 Business Overview
9.6.5 Bsim2 Recent Developments
9.7 Celgene Corporation
9.7.1 Celgene Corporation Amyloidosis Therapeutics Basic Information
9.7.2 Celgene Corporation Amyloidosis Therapeutics Product Overview
9.7.3 Celgene Corporation Amyloidosis Therapeutics Product Market Performance
9.7.4 Celgene Corporation Business Overview
9.7.5 Celgene Corporation Recent Developments
9.8 Millennium Pharmaceuticals, Inc.
9.8.1 Millennium Pharmaceuticals, Inc. Amyloidosis Therapeutics Basic Information
9.8.2 Millennium Pharmaceuticals, Inc. Amyloidosis Therapeutics Product Overview
9.8.3 Millennium Pharmaceuticals, Inc. Amyloidosis Therapeutics Product Market Performance
9.8.4 Millennium Pharmaceuticals, Inc. Business Overview
9.8.5 Millennium Pharmaceuticals, Inc. Recent Developments
9.9 Onyx Pharmaceuticals, Inc.
9.9.1 Onyx Pharmaceuticals, Inc. Amyloidosis Therapeutics Basic Information
9.9.2 Onyx Pharmaceuticals, Inc. Amyloidosis Therapeutics Product Overview
9.9.3 Onyx Pharmaceuticals, Inc. Amyloidosis Therapeutics Product Market Performance
9.9.4 Onyx Pharmaceuticals, Inc. Business Overview
9.9.5 Onyx Pharmaceuticals, Inc. Recent Developments
9.10 GlaxoSmithKline Plc
9.10.1 GlaxoSmithKline Plc Amyloidosis Therapeutics Basic Information
9.10.2 GlaxoSmithKline Plc Amyloidosis Therapeutics Product Overview
9.10.3 GlaxoSmithKline Plc Amyloidosis Therapeutics Product Market Performance
9.10.4 GlaxoSmithKline Plc Business Overview
9.10.5 GlaxoSmithKline Plc Recent Developments
9.11 Isis Pharmaceuticals, Inc.
9.11.1 Isis Pharmaceuticals, Inc. Amyloidosis Therapeutics Basic Information
9.11.2 Isis Pharmaceuticals, Inc. Amyloidosis Therapeutics Product Overview
9.11.3 Isis Pharmaceuticals, Inc. Amyloidosis Therapeutics Product Market Performance
9.11.4 Isis Pharmaceuticals, Inc. Business Overview
9.11.5 Isis Pharmaceuticals, Inc. Recent Developments
9.12 Prothena Corporation Plc
9.12.1 Prothena Corporation Plc Amyloidosis Therapeutics Basic Information
9.12.2 Prothena Corporation Plc Amyloidosis Therapeutics Product Overview
9.12.3 Prothena Corporation Plc Amyloidosis Therapeutics Product Market Performance
9.12.4 Prothena Corporation Plc Business Overview
9.12.5 Prothena Corporation Plc Recent Developments
9.13 SOM Innovation Biotech SL
9.13.1 SOM Innovation Biotech SL Amyloidosis Therapeutics Basic Information
9.13.2 SOM Innovation Biotech SL Amyloidosis Therapeutics Product Overview
9.13.3 SOM Innovation Biotech SL Amyloidosis Therapeutics Product Market Performance
9.13.4 SOM Innovation Biotech SL Business Overview
9.13.5 SOM Innovation Biotech SL Recent Developments
10 AMYLOIDOSIS THERAPEUTICS MARKET FORECAST BY REGION
10.1 Global Amyloidosis Therapeutics Market Size Forecast
10.2 Global Amyloidosis Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Amyloidosis Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Amyloidosis Therapeutics Market Size Forecast by Region
10.2.4 South America Amyloidosis Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Amyloidosis Therapeutics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Amyloidosis Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Amyloidosis Therapeutics by Type (2025-2030)
11.1.2 Global Amyloidosis Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Amyloidosis Therapeutics by Type (2025-2030)
11.2 Global Amyloidosis Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Amyloidosis Therapeutics Sales (Kilotons) Forecast by Application
11.2.2 Global Amyloidosis Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Amyloidosis Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Amyloidosis Therapeutics Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Amyloidosis Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Amyloidosis Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Amyloidosis Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amyloidosis Therapeutics as of 2022)
Table 10. Global Market Amyloidosis Therapeutics Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Amyloidosis Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Amyloidosis Therapeutics Product Type
Table 13. Global Amyloidosis Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Amyloidosis Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Amyloidosis Therapeutics Market Challenges
Table 22. Global Amyloidosis Therapeutics Sales by Type (Kilotons)
Table 23. Global Amyloidosis Therapeutics Market Size by Type (M USD)
Table 24. Global Amyloidosis Therapeutics Sales (Kilotons) by Type (2019-2024)
Table 25. Global Amyloidosis Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Amyloidosis Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Amyloidosis Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Amyloidosis Therapeutics Price (USD/Ton) by Type (2019-2024)
Table 29. Global Amyloidosis Therapeutics Sales (Kilotons) by Application
Table 30. Global Amyloidosis Therapeutics Market Size by Application
Table 31. Global Amyloidosis Therapeutics Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Amyloidosis Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Amyloidosis Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Amyloidosis Therapeutics Market Share by Application (2019-2024)
Table 35. Global Amyloidosis Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Amyloidosis Therapeutics Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Amyloidosis Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Amyloidosis Therapeutics Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Amyloidosis Therapeutics Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Amyloidosis Therapeutics Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Amyloidosis Therapeutics Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Amyloidosis Therapeutics Sales by Region (2019-2024) & (Kilotons)
Table 43. Pfizer Inc. Amyloidosis Therapeutics Basic Information
Table 44. Pfizer Inc. Amyloidosis Therapeutics Product Overview
Table 45. Pfizer Inc. Amyloidosis Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Pfizer Inc. Business Overview
Table 47. Pfizer Inc. Amyloidosis Therapeutics SWOT Analysis
Table 48. Pfizer Inc. Recent Developments
Table 49. ProteoTech, Inc. Amyloidosis Therapeutics Basic Information
Table 50. ProteoTech, Inc. Amyloidosis Therapeutics Product Overview
Table 51. ProteoTech, Inc. Amyloidosis Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. ProteoTech, Inc. Business Overview
Table 53. ProteoTech, Inc. Amyloidosis Therapeutics SWOT Analysis
Table 54. ProteoTech, Inc. Recent Developments
Table 55. Alnylam Pharmaceuticals, Inc. Amyloidosis Therapeutics Basic Information
Table 56. Alnylam Pharmaceuticals, Inc. Amyloidosis Therapeutics Product Overview
Table 57. Alnylam Pharmaceuticals, Inc. Amyloidosis Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Alnylam Pharmaceuticals, Inc. Amyloidosis Therapeutics SWOT Analysis
Table 59. Alnylam Pharmaceuticals, Inc. Business Overview
Table 60. Alnylam Pharmaceuticals, Inc. Recent Developments
Table 61. Arcturus Therapeutics, Inc Amyloidosis Therapeutics Basic Information
Table 62. Arcturus Therapeutics, Inc Amyloidosis Therapeutics Product Overview
Table 63. Arcturus Therapeutics, Inc Amyloidosis Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Arcturus Therapeutics, Inc Business Overview
Table 65. Arcturus Therapeutics, Inc Recent Developments
Table 66. Bellus Health Inc. Amyloidosis Therapeutics Basic Information
Table 67. Bellus Health Inc. Amyloidosis Therapeutics Product Overview
Table 68. Bellus Health Inc. Amyloidosis Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Bellus Health Inc. Business Overview
Table 70. Bellus Health Inc. Recent Developments
Table 71. Bsim2 Amyloidosis Therapeutics Basic Information
Table 72. Bsim2 Amyloidosis Therapeutics Product Overview
Table 73. Bsim2 Amyloidosis Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Bsim2 Business Overview
Table 75. Bsim2 Recent Developments
Table 76. Celgene Corporation Amyloidosis Therapeutics Basic Information
Table 77. Celgene Corporation Amyloidosis Therapeutics Product Overview
Table 78. Celgene Corporation Amyloidosis Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Celgene Corporation Business Overview
Table 80. Celgene Corporation Recent Developments
Table 81. Millennium Pharmaceuticals, Inc. Amyloidosis Therapeutics Basic Information
Table 82. Millennium Pharmaceuticals, Inc. Amyloidosis Therapeutics Product Overview
Table 83. Millennium Pharmaceuticals, Inc. Amyloidosis Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Millennium Pharmaceuticals, Inc. Business Overview
Table 85. Millennium Pharmaceuticals, Inc. Recent Developments
Table 86. Onyx Pharmaceuticals, Inc. Amyloidosis Therapeutics Basic Information
Table 87. Onyx Pharmaceuticals, Inc. Amyloidosis Therapeutics Product Overview
Table 88. Onyx Pharmaceuticals, Inc. Amyloidosis Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Onyx Pharmaceuticals, Inc. Business Overview
Table 90. Onyx Pharmaceuticals, Inc. Recent Developments
Table 91. GlaxoSmithKline Plc Amyloidosis Therapeutics Basic Information
Table 92. GlaxoSmithKline Plc Amyloidosis Therapeutics Product Overview
Table 93. GlaxoSmithKline Plc Amyloidosis Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. GlaxoSmithKline Plc Business Overview
Table 95. GlaxoSmithKline Plc Recent Developments
Table 96. Isis Pharmaceuticals, Inc. Amyloidosis Therapeutics Basic Information
Table 97. Isis Pharmaceuticals, Inc. Amyloidosis Therapeutics Product Overview
Table 98. Isis Pharmaceuticals, Inc. Amyloidosis Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Isis Pharmaceuticals, Inc. Business Overview
Table 100. Isis Pharmaceuticals, Inc. Recent Developments
Table 101. Prothena Corporation Plc Amyloidosis Therapeutics Basic Information
Table 102. Prothena Corporation Plc Amyloidosis Therapeutics Product Overview
Table 103. Prothena Corporation Plc Amyloidosis Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Prothena Corporation Plc Business Overview
Table 105. Prothena Corporation Plc Recent Developments
Table 106. SOM Innovation Biotech SL Amyloidosis Therapeutics Basic Information
Table 107. SOM Innovation Biotech SL Amyloidosis Therapeutics Product Overview
Table 108. SOM Innovation Biotech SL Amyloidosis Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. SOM Innovation Biotech SL Business Overview
Table 110. SOM Innovation Biotech SL Recent Developments
Table 111. Global Amyloidosis Therapeutics Sales Forecast by Region (2025-2030) & (Kilotons)
Table 112. Global Amyloidosis Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Amyloidosis Therapeutics Sales Forecast by Country (2025-2030) & (Kilotons)
Table 114. North America Amyloidosis Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Amyloidosis Therapeutics Sales Forecast by Country (2025-2030) & (Kilotons)
Table 116. Europe Amyloidosis Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Amyloidosis Therapeutics Sales Forecast by Region (2025-2030) & (Kilotons)
Table 118. Asia Pacific Amyloidosis Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Amyloidosis Therapeutics Sales Forecast by Country (2025-2030) & (Kilotons)
Table 120. South America Amyloidosis Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Amyloidosis Therapeutics Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Amyloidosis Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Amyloidosis Therapeutics Sales Forecast by Type (2025-2030) & (Kilotons)
Table 124. Global Amyloidosis Therapeutics Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Amyloidosis Therapeutics Price Forecast by Type (2025-2030) & (USD/Ton)
Table 126. Global Amyloidosis Therapeutics Sales (Kilotons) Forecast by Application (2025-2030)
Table 127. Global Amyloidosis Therapeutics Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Amyloidosis Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Amyloidosis Therapeutics Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Amyloidosis Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Amyloidosis Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Amyloidosis Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amyloidosis Therapeutics as of 2022)
Table 10. Global Market Amyloidosis Therapeutics Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Amyloidosis Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Amyloidosis Therapeutics Product Type
Table 13. Global Amyloidosis Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Amyloidosis Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Amyloidosis Therapeutics Market Challenges
Table 22. Global Amyloidosis Therapeutics Sales by Type (Kilotons)
Table 23. Global Amyloidosis Therapeutics Market Size by Type (M USD)
Table 24. Global Amyloidosis Therapeutics Sales (Kilotons) by Type (2019-2024)
Table 25. Global Amyloidosis Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Amyloidosis Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Amyloidosis Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Amyloidosis Therapeutics Price (USD/Ton) by Type (2019-2024)
Table 29. Global Amyloidosis Therapeutics Sales (Kilotons) by Application
Table 30. Global Amyloidosis Therapeutics Market Size by Application
Table 31. Global Amyloidosis Therapeutics Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Amyloidosis Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Amyloidosis Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Amyloidosis Therapeutics Market Share by Application (2019-2024)
Table 35. Global Amyloidosis Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Amyloidosis Therapeutics Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Amyloidosis Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Amyloidosis Therapeutics Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Amyloidosis Therapeutics Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Amyloidosis Therapeutics Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Amyloidosis Therapeutics Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Amyloidosis Therapeutics Sales by Region (2019-2024) & (Kilotons)
Table 43. Pfizer Inc. Amyloidosis Therapeutics Basic Information
Table 44. Pfizer Inc. Amyloidosis Therapeutics Product Overview
Table 45. Pfizer Inc. Amyloidosis Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Pfizer Inc. Business Overview
Table 47. Pfizer Inc. Amyloidosis Therapeutics SWOT Analysis
Table 48. Pfizer Inc. Recent Developments
Table 49. ProteoTech, Inc. Amyloidosis Therapeutics Basic Information
Table 50. ProteoTech, Inc. Amyloidosis Therapeutics Product Overview
Table 51. ProteoTech, Inc. Amyloidosis Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. ProteoTech, Inc. Business Overview
Table 53. ProteoTech, Inc. Amyloidosis Therapeutics SWOT Analysis
Table 54. ProteoTech, Inc. Recent Developments
Table 55. Alnylam Pharmaceuticals, Inc. Amyloidosis Therapeutics Basic Information
Table 56. Alnylam Pharmaceuticals, Inc. Amyloidosis Therapeutics Product Overview
Table 57. Alnylam Pharmaceuticals, Inc. Amyloidosis Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Alnylam Pharmaceuticals, Inc. Amyloidosis Therapeutics SWOT Analysis
Table 59. Alnylam Pharmaceuticals, Inc. Business Overview
Table 60. Alnylam Pharmaceuticals, Inc. Recent Developments
Table 61. Arcturus Therapeutics, Inc Amyloidosis Therapeutics Basic Information
Table 62. Arcturus Therapeutics, Inc Amyloidosis Therapeutics Product Overview
Table 63. Arcturus Therapeutics, Inc Amyloidosis Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Arcturus Therapeutics, Inc Business Overview
Table 65. Arcturus Therapeutics, Inc Recent Developments
Table 66. Bellus Health Inc. Amyloidosis Therapeutics Basic Information
Table 67. Bellus Health Inc. Amyloidosis Therapeutics Product Overview
Table 68. Bellus Health Inc. Amyloidosis Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Bellus Health Inc. Business Overview
Table 70. Bellus Health Inc. Recent Developments
Table 71. Bsim2 Amyloidosis Therapeutics Basic Information
Table 72. Bsim2 Amyloidosis Therapeutics Product Overview
Table 73. Bsim2 Amyloidosis Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Bsim2 Business Overview
Table 75. Bsim2 Recent Developments
Table 76. Celgene Corporation Amyloidosis Therapeutics Basic Information
Table 77. Celgene Corporation Amyloidosis Therapeutics Product Overview
Table 78. Celgene Corporation Amyloidosis Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Celgene Corporation Business Overview
Table 80. Celgene Corporation Recent Developments
Table 81. Millennium Pharmaceuticals, Inc. Amyloidosis Therapeutics Basic Information
Table 82. Millennium Pharmaceuticals, Inc. Amyloidosis Therapeutics Product Overview
Table 83. Millennium Pharmaceuticals, Inc. Amyloidosis Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Millennium Pharmaceuticals, Inc. Business Overview
Table 85. Millennium Pharmaceuticals, Inc. Recent Developments
Table 86. Onyx Pharmaceuticals, Inc. Amyloidosis Therapeutics Basic Information
Table 87. Onyx Pharmaceuticals, Inc. Amyloidosis Therapeutics Product Overview
Table 88. Onyx Pharmaceuticals, Inc. Amyloidosis Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Onyx Pharmaceuticals, Inc. Business Overview
Table 90. Onyx Pharmaceuticals, Inc. Recent Developments
Table 91. GlaxoSmithKline Plc Amyloidosis Therapeutics Basic Information
Table 92. GlaxoSmithKline Plc Amyloidosis Therapeutics Product Overview
Table 93. GlaxoSmithKline Plc Amyloidosis Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. GlaxoSmithKline Plc Business Overview
Table 95. GlaxoSmithKline Plc Recent Developments
Table 96. Isis Pharmaceuticals, Inc. Amyloidosis Therapeutics Basic Information
Table 97. Isis Pharmaceuticals, Inc. Amyloidosis Therapeutics Product Overview
Table 98. Isis Pharmaceuticals, Inc. Amyloidosis Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Isis Pharmaceuticals, Inc. Business Overview
Table 100. Isis Pharmaceuticals, Inc. Recent Developments
Table 101. Prothena Corporation Plc Amyloidosis Therapeutics Basic Information
Table 102. Prothena Corporation Plc Amyloidosis Therapeutics Product Overview
Table 103. Prothena Corporation Plc Amyloidosis Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Prothena Corporation Plc Business Overview
Table 105. Prothena Corporation Plc Recent Developments
Table 106. SOM Innovation Biotech SL Amyloidosis Therapeutics Basic Information
Table 107. SOM Innovation Biotech SL Amyloidosis Therapeutics Product Overview
Table 108. SOM Innovation Biotech SL Amyloidosis Therapeutics Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. SOM Innovation Biotech SL Business Overview
Table 110. SOM Innovation Biotech SL Recent Developments
Table 111. Global Amyloidosis Therapeutics Sales Forecast by Region (2025-2030) & (Kilotons)
Table 112. Global Amyloidosis Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Amyloidosis Therapeutics Sales Forecast by Country (2025-2030) & (Kilotons)
Table 114. North America Amyloidosis Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Amyloidosis Therapeutics Sales Forecast by Country (2025-2030) & (Kilotons)
Table 116. Europe Amyloidosis Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Amyloidosis Therapeutics Sales Forecast by Region (2025-2030) & (Kilotons)
Table 118. Asia Pacific Amyloidosis Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Amyloidosis Therapeutics Sales Forecast by Country (2025-2030) & (Kilotons)
Table 120. South America Amyloidosis Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Amyloidosis Therapeutics Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Amyloidosis Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Amyloidosis Therapeutics Sales Forecast by Type (2025-2030) & (Kilotons)
Table 124. Global Amyloidosis Therapeutics Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Amyloidosis Therapeutics Price Forecast by Type (2025-2030) & (USD/Ton)
Table 126. Global Amyloidosis Therapeutics Sales (Kilotons) Forecast by Application (2025-2030)
Table 127. Global Amyloidosis Therapeutics Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Amyloidosis Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Amyloidosis Therapeutics Market Size (M USD), 2019-2030
Figure 5. Global Amyloidosis Therapeutics Market Size (M USD) (2019-2030)
Figure 6. Global Amyloidosis Therapeutics Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Amyloidosis Therapeutics Market Size by Country (M USD)
Figure 11. Amyloidosis Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Amyloidosis Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Amyloidosis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Amyloidosis Therapeutics Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Amyloidosis Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Amyloidosis Therapeutics Market Share by Type
Figure 18. Sales Market Share of Amyloidosis Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Amyloidosis Therapeutics by Type in 2023
Figure 20. Market Size Share of Amyloidosis Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Amyloidosis Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Amyloidosis Therapeutics Market Share by Application
Figure 24. Global Amyloidosis Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Amyloidosis Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Amyloidosis Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Amyloidosis Therapeutics Market Share by Application in 2023
Figure 28. Global Amyloidosis Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Amyloidosis Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Amyloidosis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Amyloidosis Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Amyloidosis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Amyloidosis Therapeutics Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Amyloidosis Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Amyloidosis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Amyloidosis Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Amyloidosis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Amyloidosis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Amyloidosis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Amyloidosis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Amyloidosis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Amyloidosis Therapeutics Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Amyloidosis Therapeutics Sales Market Share by Region in 2023
Figure 44. China Amyloidosis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Amyloidosis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Amyloidosis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Amyloidosis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Amyloidosis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Amyloidosis Therapeutics Sales and Growth Rate (Kilotons)
Figure 50. South America Amyloidosis Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Amyloidosis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Amyloidosis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Amyloidosis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Amyloidosis Therapeutics Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Amyloidosis Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Amyloidosis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Amyloidosis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Amyloidosis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Amyloidosis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Amyloidosis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Amyloidosis Therapeutics Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Amyloidosis Therapeutics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Amyloidosis Therapeutics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Amyloidosis Therapeutics Market Share Forecast by Type (2025-2030)
Figure 65. Global Amyloidosis Therapeutics Sales Forecast by Application (2025-2030)
Figure 66. Global Amyloidosis Therapeutics Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Amyloidosis Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Amyloidosis Therapeutics Market Size (M USD), 2019-2030
Figure 5. Global Amyloidosis Therapeutics Market Size (M USD) (2019-2030)
Figure 6. Global Amyloidosis Therapeutics Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Amyloidosis Therapeutics Market Size by Country (M USD)
Figure 11. Amyloidosis Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Amyloidosis Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Amyloidosis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Amyloidosis Therapeutics Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Amyloidosis Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Amyloidosis Therapeutics Market Share by Type
Figure 18. Sales Market Share of Amyloidosis Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Amyloidosis Therapeutics by Type in 2023
Figure 20. Market Size Share of Amyloidosis Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Amyloidosis Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Amyloidosis Therapeutics Market Share by Application
Figure 24. Global Amyloidosis Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Amyloidosis Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Amyloidosis Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Amyloidosis Therapeutics Market Share by Application in 2023
Figure 28. Global Amyloidosis Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Amyloidosis Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Amyloidosis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Amyloidosis Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Amyloidosis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Amyloidosis Therapeutics Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Amyloidosis Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Amyloidosis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Amyloidosis Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Amyloidosis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Amyloidosis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Amyloidosis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Amyloidosis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Amyloidosis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Amyloidosis Therapeutics Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Amyloidosis Therapeutics Sales Market Share by Region in 2023
Figure 44. China Amyloidosis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Amyloidosis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Amyloidosis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Amyloidosis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Amyloidosis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Amyloidosis Therapeutics Sales and Growth Rate (Kilotons)
Figure 50. South America Amyloidosis Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Amyloidosis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Amyloidosis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Amyloidosis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Amyloidosis Therapeutics Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Amyloidosis Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Amyloidosis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Amyloidosis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Amyloidosis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Amyloidosis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Amyloidosis Therapeutics Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Amyloidosis Therapeutics Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Amyloidosis Therapeutics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Amyloidosis Therapeutics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Amyloidosis Therapeutics Market Share Forecast by Type (2025-2030)
Figure 65. Global Amyloidosis Therapeutics Sales Forecast by Application (2025-2030)
Figure 66. Global Amyloidosis Therapeutics Market Share Forecast by Application (2025-2030)
